fbpx

Gian Life Care IPO Dates, Size, Allotment, Bid Details, GMP & DRHP

Let’s have a detailed review of the company and analytics of the Gian Life Care IPO release date, IPO offer price, subscription, Gian Life Care IPO allotment, grey market price and other details like the company’s background, its financial positions, its promoters and other related things.


Gian Life Care IPO Review & Ratings

IPO Ratings & Review
CriteriaRatings
Industry Sentiments7.5/10
Industry Ranking7.1/10
Company Background7.3/10
Company Reputation7.2/10
Competitive Edge7.4/10
Financial Statements7.1/10
Popularity Index7.4/10
Promoters Reputation7.7/10
Retail Appetite7.1/10
Top Brokers Review7.0/10
Overall Ratings7.3/10
Star Ratings★★★★☆

Summary of Gian Life Care IPO

Gian Life Care IPOThe Company was incorporated on November 06, 2018, under the provisions of the Companies Act, 2013 by Registrar of Companies, Kanpur. On March 01, 2019 the company took over the entire running business of M/s Gian Pathology and XRays, a proprietorship concern of the promoter Mr. Arun Kumar Gupta with a view to provide diagnostic and related healthcare tests and services.

They are primarily engaged in the business of providing diagnostic and related healthcare tests and services in Kanpur and nearby areas. They provide a broad range of diagnostic and related healthcare tests and services such as patient diagnosis services and prevention and wellness diagnosis services to their patients and healthcare providers. Their customers include individual patients, hospitals, other healthcare providers and corporate customers.

The Promoters of this company are Mr. Arun Kumar Gupta. The lead manager to the issue is Hem Securities Limited and the Registrar to this issue is Cameo Corporate Services Limited.

From FY 2016-17 to FY 2018-19, as per the Restated Financial Statements

As per restated financial statements for the period ended April 30, 2019, and the period ended on March 31, 2019, the total revenue of the Company stood at Rs.55.32 lakhs and Rs. 55.83 lakh, respectively. Further, the Profit after tax for the period ended April 30, 2019, and the period ended on March 31, 2019, stood at Rs. 10.04 lakh and Rs. 9.08 lakhs respectively.



Gian Life Care IPO Date

The opening and the closing date of Gian Life Care IPO is not known yet.


Gian Life Care IPO Subscription

Day / DateQIBNIIRIITotal Subscription
1st Day – 
2nd Day – 
3rd Day – 
4th Day – 
5th Day – 
Shares Offered or Net Issue

The shares subscribed by the public will be updated herein on a daily basis, once the IPO is open for subscription.


Gian Life Care IPO Allotment Status

Here, you can find the Allotment Status of this IPO.


Gian Life Care IPO Price Band

The face value of each share is Rs 10, but the price band of the IPO is not yet disclosed. 


Gian Life Care IPO Size & Share Offering

Issue of 14,16,000 Equity Shares of face value of Rs.10/- each for cash at a price of Rs. [ ] per Equity Share (including a share premium of Rs.[ ] per Equity share) aggregating Rs. [ ] lakhs.


Gian Life Care Limited – Company Overview

The Company was incorporated as a public limited company under the Companies Act, 2013 and registered with the Registrar of Companies, Uttar Pradesh, Kanpur, pursuant to a certificate of incorporation dated November 06, 2018. Subsequently, the Company has acquired the entire business of M/s Gian Pathology & X-Ray w.e.f. March 01, 2019 vide the Business Transfer Agreement executed on March 01 st, 2019.

Business strategies of Gian Life Care Limited

  • Grow their wellness and preventive check offerings and expand their test range.
  • Continue to focus on providing quality diagnostic and related healthcare tests and services.
  • Attract and retain talented employee
  • Enhancing Operating Effectiveness and Efficiency

Gian Life Care Limited – Financial Statements

A quick look into the past financial performance of the company to understand its performance of business and evaluate the growth prospectus:

Financial Summary of Gian Life Care IPO

On the basis of Standalone statement:-

Amount (in INR & lakhs)  
30-Apr-1931-Mar-19
Total Assets791.87781.62
Total Revenue55.9256.32
Total Expense43.6542.74
Profit After Tax9.0810.04

Earnings per Equity Share (in lakhs)

31-Apr-1931-Mar-19
Basic & Diluted0.280.31

From the above statements, one could find that Gian Life Care Limited may perform well.


Gian Life Care IPO – Promoters

The Promoter of this company is:

  • Mr.Arun Kumar Gupta

List of Related Parties (Key Managerial Personnel)

  • Mr. Arun Kumar Gupta – Chairman & Managing Director
  • Ms. Rashika Agarwal – Non-Executive Director
  • Mrs. Avani Gupta – CFO

Interest in promotion of the Company

All the Directors may be deemed to be interested to the extent of fees payable to them for attending meetings of the Board of Directors or a committee thereof as well as to the extent of remuneration and reimbursement of expenses payable to them under the Articles, and to the extent of remuneration paid to them for services rendered as an officer or employee of the Company.

Property Interest

Except as disclosed in the Draft Prospectus and the property purchased by the company through the purchase agreement entered between the company and the Managing Director for purchase of the running business of Gian Pathology and X Rays along with the assets and liabilities, the Directors do not have any other interest in any property acquired/rented by the Company or proposed to be acquired by them as on date of the Draft Prospectus.

Interest in Intellectual Rights of the Company

Except as disclosed in the Draft Prospectus, the Promoter is not interested in any entity which holds any intellectual property rights that are used by the Company.


Gian Life Care IPO Offer Details or Issue Details

Particulars No. Of Equity Shares
 Equity Shares Offered Upto 14,16,000 Equity Shares of M 10 each for cash at a
price of M [●] per share aggregating M [●] lakhs.
 Of which:
 Reserved for Market Makers Upto [●] Equity Shares of M 10 each for cash at a
price of M [●] per share aggregating M [●] lakhs
 Net Issue to the Public Upto [●] Equity Shares of M 10 each for cash at a
price of M [●] per share aggregating M [●] lakhs
 Of which:
 Retail Investors Portion Upto [●] Equity Shares of M 10 each at a price of M
[●] per Equity Share will be available for allocation for
Investors of up to M 2.00 lakhs
 Non-Retail Investors PortionUpto [●] Equity Shares of M 10 each at a price of M
[●] per Equity Share will be available for allocation for
Investors of up to M 2.00 lakhs
 Equity Shares outstanding prior to the Issue32,84,694 Equity Shares
 Equity Shares outstanding after the IssueUpto 47,00,694 Equity Shares

Gian Life Care IPO Issue Object

These are the IPO Issue Objects of the company

  • To open processing center in nearby cites of Kanpur (Jhansi, Banda, Faizabad, Unnao)
  • Purchase advanced machinery and equipment
  • Repayment/pre-payment, of certain borrowings availed by the Company
  • To meet Working Capital requirements
  • General Corporate Purpose
  • To meet issue expenses

Gian Life Care IPO – Basis of the Offer Price

The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.

Qualitative factors are:

  • Wide range of specialized tests with an emphasis on wellness and preventive healthcare.
  • Experienced leadership team with strong industry expertise and successful track record.
  • Customer-centric approach and focus on customer satisfaction
  • Quality Compliance

The relevant quantitative factors are:

On the basis of standalone statement:-

Basic & Diluted EPSRONW NAV (Rs.)
31-Apr-190.282.60%10.62
31-Mar-190.3190.94%0.34
  • Price to Earnings (P/E) ratio in relation to Issue Price of Rs. [ ]:
ParticularsP/E ratio
Highest48.15
Average37.06
Lowest25.97
  • Competitive Peers:
Sr. No. ParticularsFace Value  (in Rs.) EPS (In Rs.)P/E RatioRONW (%) NAV (In Rs.)
1Gian Life Care Limited100.3190.94%
2Dr. Lal Path Labs Ltd1024.1948.1521.20%
3Thyrocare Technologies Ltd1017.8425.9720.89%

Gian Life Care IPO Lead Managers

Lead Managers
HEM SECURITIES LIMITED
904-A Wing, Naman Midtown, Senapati Bapat Marg, Elphinstone Road,
Lower Parel, Mumbai – 400013, India
Tel. No.: +91- 022-49060000, Fax No. – +91 – 022 – 22625991
Website: www.hemsecurities.com
Email:
Investor Grievance Email:
ContactPerson: Mr. Anil Bhargava
SEBIRegn.No. INM000010981

Gian Life Care IPO Registrar to offer

Registrar to the Offer
CAMEO CORPORATE SERVICES LTD.
Submaramanian Building, 1 Club House Road,
Chennai 600 002.
Tel No.: +91-44-40020700
Fax No.: +91-44-2846 0129
E-mail: ;
Website: www.cameoindia.com
Contact Person: Mr. R. D. Ramasamy
SEBI Registration No: INR000003753

Gian Life Care IPO Other Details:

  • Statutory Auditor – M/s P. D. Dalal & Co., Chartered Accountants
  • Peer Review Auditor – NA
  • Bankers to the Company – NA

Gian Life Care IPO Grey Market Premium

The Gian Life Care IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is X. 


Subscribe to Gian Life Care IPO

Fill the Details Below
  1. Subscribe to IPOOpen Demat AccountBecome Sub Broker


Gian Life Care IPO News

News 1 – Download DRHP Prospectus


Market Guide

What is IPO?
IPO Investment
Upcoming IPOs
 IPO Valuation

Featured Topics

Best Discount Broker in India
Top 10 Sub Broker Partner in India
Best Stock Broker in India
Sub Broker Franchise
Best Demat Account
Brokerage Calculator
Best Full Service Broker in India
Broking Franchisee
 Best Intraday Trading Brokers in India

Leave a Reply

Your email address will not be published. Required fields are marked *

Get 90% Discount on Brokerage Now! Open Demat Account
×

Share your details & Become Sub Broker Now!

  1. Become Sub BrokerOpen Demat Account

Offer valid for limited time.

×

Share your details & Open Demat A/C Now!

  1. Open Demat AccountBecome Sub Broker

Offer valid for limited time.

×

Share your details & Get IPO Allotment Now!

  1. Invest in IPOOpen Demat Account

Offer valid for limited time.

×

Share your details & Invest in PMS Now!

  1. Invest in PMSOpen Demat Account

Offer valid for limited time.